takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Executive Profile*
Deborah Dunsire M.D.Director, Member of Science & Technology Committee and Member of Corporate Governance & Compliance Committee, Allergan Inc. |
| Age | Total Calculated Compensation | This person is connected to 154 board members in 3 different organizations across 7 different industries. See Board Relationships |
| 49 | $553,920 |
Background*
Dr. Deborah Dunsire, MD served as the President and Chief Executive Officer at Millennium Pharmaceuticals, Inc. since July 2005 until May 2013. Dr. Dunsire served as Corporate Officer at Millennium Pharmaceuticals, Inc. from June 24, 2011 to June 26, 2012. She joined Millennium in July 2005 with nearly 20 years of experience in the commercial, operational, clinical and scientific aspects of the pharmaceutical industry. She served as Corporate Officer at Takeda Pharmaceutical ...
Corporate Headquarters*1-1, Doshomachi 4-ChomeOsaka, -- 540-8645 Japan Phone: 81 6 6204 2111 Fax: 81 6 6204 2880 Board Members Memberships*Director Director At Large 2006-Present Director, Member of Science & Technology Committee and Member of Corporate Governance & Compliance Committee 2012-2013 Former Chief Executive Officer, President and Director 2012-N/A Former Director, Chief Executive Officer of Millennium Pharmaceuticals Inc and President of Millennium Pharmaceuticals Inc
Education*Unknown/Other Education Wits Medical School Doctorate University of the Witwatersrand
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*
|
| Recently Viewed | |||
| 4502:JP | ¥4,745.00 JPY | -55.00 | |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Leonard S. Schleifer M.D., Ph.D. | Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee Regeneron Pharmaceuticals, Inc. | $3.3M |
| Paul M. Bisaro | Chief Executive Officer, President and Director Actavis, Inc. | $2.4M |
| J. Michael Pearson | Chairman and Chief Executive Officer Valeant Pharmaceuticals International, Inc. | $1.7M |
| Flemming Ornskov M.D., MBA, MPH | Chief Executive Officer, Head of Human Genetic Therapies and Director Shire plc | -- |
| Yoshihiko Hatanaka | Chief Executive Officer, President and Representative Director Astellas Pharma, Inc. | -- | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








